Mucin profiles in signet-ring cell carcinoma

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 6, 2006, Pages 799-804

  Nguyen, Minh D ^a   Plasil, Brian ^a   Wen, Ping ^a   Frankel, Wendy L ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN; MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 5AC; MUCIN 6;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PROTEIN EXPRESSION; SCORING SYSTEM; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TUMOR LOCALIZATION; TUMOR ORIGIN; CLASSIFICATION; CYTOPLASM; FEMALE; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY;

CARCINOMA, SIGNET RING CELL; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 33745025822     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6:339-353.
2. Pinto-de-Sousa J, David L, Reis CA, Comes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC, and MUC6 expression in the evaluation of differentiation and clinico-biological behavior of gastric carcinoma. Virchows Arch. 2002;440:304-310.
3. Carraway K, Ramsauer V, Haq B, Carothers Carraway C. Cell signaling through membrane mucins. BioEssays. 2002;25:66-71.
4. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004;23(1-2):77-99.
5. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 2003;27:571-578.
6. Matsukita S, Nomoto M, Kitajima S, et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology. 2003;42:26-36.
7. Basbaum C, Lemjabbar H, Longphre M, Li D, Censch E, McNamara N. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med. 1999;160(5, pt 2):S44-48.
8. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell. 1996;7:565-577.
9. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) Overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol. 1995;129:255-265.
10. Matsuda K, Masaki T, Watanabe T, et al. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn J Clin Oncol. 2000;30(2):89-94.
11. Baldus SE, Monig SP, Hanisch FG, et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis and sial-Lewis antigens in colorectal adenocarcinoma. Histopathology. 2002;40:440-449.
12. Lau SK, Weiss LM, Chu PC. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. Am J Clin Pathol. 2004;122:61-69.
13. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410.
14. Chu PC, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892.
15. Kuroda N, Yamasaki I, Nakayama H, et al. Prostatic signet-ring cell carcinoma: case report and literature review. Pathol Int. 1999;49:457-461.
16. Torbenson M, Dhir R, Nangia A, Becich MJ, Kapadia SB. Prostatic carcinoma with signet ring cells: a clinicopathologic immunohistochemical analysis of 12 cases, with review of literature. Mod Pathol. 1998;11:552-559.
17. Merchant SH, Amin MB, Tamboli P, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001;25:1515-1519.
18. Kim DH, Kim JW, Cho JH, et al. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Int J Oncol. 2005;27:957-964.
19. Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch. 2004;444:224-230.
20. Aihara R, Mochiki E, Kamiyama Y, Kamimura H, Asao T, Kuwano H. Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors. Dig Dis Sci. 2004;49:417-424.
21. Baldus S, Monig S, Huxel S, et al. MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res. 2004;10:2790-2796.
22. Losi L, Scarselli A, Benatti P, et al. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathol Res Pract. 2004;200:371-377.